Merck to Acquire Verona Pharma for $10 Billion in Strategic Push Beyond Keytruda
FDA Approves Merck’s RSV Shot for Infants, Intensifying Competition with Sanofi and AstraZeneca
Winners and Losers: Sectors That Led and Lagged in This Week’s Market Rally
Markets on May 14, 2025: Techs Soar, Healthcare Stumbles, and Small-Caps Steal the Show
Trump's Drug Price Order Spooks Markets - Then Sparks a Comeback
Pump Radar
Stock Alerts